New study aims to predict dangerous blood clots in cancer patients on chemo
NCT ID NCT07196020
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Cancer patients face a higher risk of blood clots during chemotherapy, but it's hard to know who is most at risk. This study will measure clotting-related biomarkers in the blood of 380 patients with ovarian, lung, stomach, or pancreatic cancer at four points during their treatment. By comparing those who develop clots with those who don't, researchers hope to develop a blood test that predicts clot risk and helps guide the safe use of blood thinners.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test that identifies which cancer patients are at high risk of blood clots during chemotherapy, allowing doctors to use blood thinners more safely and effectively.
What could go wrong
This is an observational study, not a treatment trial. It is still in early stages and may not produce a reliable prediction tool. The results may not apply to all cancer types or treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cork University Hospital
RECRUITINGCork, Ireland, T12 DC4A, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mater Misericordiae University Hospital
RECRUITINGDublin, Ireland, D07R2WY, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Trinity Cancer St. James Cancer Institute
RECRUITINGDublin, Ireland, D08W9RT, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••